Haolong Li
- Molecular Biology
- Pulmonary and Respiratory Medicine top 10%
- Cancer Research top 5%
- Oncology
- Biomedical Engineering
- Topics
- Ubiquitin and proteasome pathways (5 papers)Prostate Cancer Treatment and Research (5 papers)Cancer-related molecular mechanisms research (4 papers)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Haolong Li
30 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 102
- Molecular Biology 689
- Pulmonary and Respiratory Medicine 367
- Cancer Research 322
- Oncology 184
- Biomedical Engineering 166
Countries citing papers authored by Haolong Li
This map shows the geographic impact of Haolong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haolong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haolong Li more than expected).
Fields of papers citing papers by Haolong Li
This network shows the impact of papers produced by Haolong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haolong Li. The network helps show where Haolong Li may publish in the future.
Co-authorship network of co-authors of Haolong Li
This figure shows the co-authorship network connecting the top 25 collaborators of Haolong Li. A scholar is included among the top collaborators of Haolong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haolong Li. Haolong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 14 | |
| 5 | 33 | |
| 6 | 8 | |
| 7 | 54 | |
| 8 | 26 | |
| 9 | 3 | |
| 10 | 24 | |
| 11 | 50 | |
| 12 | 4 | |
| 13 | Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cellsbreakdown → | 256 |
| 14 | 9 | |
| 15 | 15 | |
| 16 | 30 | |
| 17 | 7 | |
| 18 | 36 | |
| 19 | 8 | |
| 20 | 30 |
About Haolong Li
Haolong Li is a scholar working on Cancer Research, Reproductive Medicine and Process Chemistry and Technology, having authored 35 papers that have together received 1.2k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (5 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related molecular mechanisms research (4 papers). The work is most often cited by research in Cancer Research (322 citations), Pulmonary and Respiratory Medicine (367 citations) and Molecular Biology (689 citations). Haolong Li has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Zhengzhi Zou, Haocai Chang, Songmao Wang, Yibing Chen, Yucen Song, Yanjun Mi, Qian Ma, Xiaofei Zhang, Benxin Hou and Jinliang Xing. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.